Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Döring

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Clinical Chemistry and Laboratory Medicine|July 9, 2008
Validation criteria for nucleic acid amplification techniques for bacterial infectionsGerd Döring, Klaus Unertl, Alexandra Heininger
American Journal of Respiratory and Critical Care Medicine|July 3, 2013
Lactate levels in airways of patients with cystic fibrosis and idiopathic pulmonary fibrosisDieter Worlitzsch, Keith C Meyer, Gerd Döring
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 22, 2011
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosisGeraint B Rogers, Lucas R Hoffman, Gerd Döring
FEMS Microbiology Reviews|June 30, 2010
Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary diseaseGerd Döring, Iyer G Parameswaran, Timothy F Murphy
Thorax|November 9, 2012
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised studyAntje Schuster, Cynthia Haliburn, Gerd Döring, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 10, 2012
Treatment of lung infection in patients with cystic fibrosis: current and future strategiesGerd Döring, Patrick Flume, Harry Heijerman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 30, 2009
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensusHarry Heijerman, Elsbeth Westerman, Steven Conway, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2010
Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infectionYang Zhang, Xiang Li, Heike Grassmé, et al.
Journal of Clinical Microbiology|September 5, 2007
Emergence of an epidemic clone of community-associated methicillin-resistant panton-valentine leucocidin-negative Staphylococcus aureus in cystic fibrosis patient populationsSilvia Campana, Priscilla Cocchi, Gerd Döring, et al.
Journal of Bacteriology|October 18, 2003
Molecular architecture of the regulatory Locus sae of Staphylococcus aureus and its impact on expression of virulence factorsAndrea Steinhuber, Christiane Goerke, Manfred G Bayer, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Clinical Chemistry and Laboratory Medicine|July 9, 2008
Validation criteria for nucleic acid amplification techniques for bacterial infectionsGerd Döring, Klaus Unertl, Alexandra Heininger
American Journal of Respiratory and Critical Care Medicine|July 3, 2013
Lactate levels in airways of patients with cystic fibrosis and idiopathic pulmonary fibrosisDieter Worlitzsch, Keith C Meyer, Gerd Döring
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 22, 2011
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosisGeraint B Rogers, Lucas R Hoffman, Gerd Döring
FEMS Microbiology Reviews|June 30, 2010
Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary diseaseGerd Döring, Iyer G Parameswaran, Timothy F Murphy
Thorax|November 9, 2012
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised studyAntje Schuster, Cynthia Haliburn, Gerd Döring, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 10, 2012
Treatment of lung infection in patients with cystic fibrosis: current and future strategiesGerd Döring, Patrick Flume, Harry Heijerman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 30, 2009
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensusHarry Heijerman, Elsbeth Westerman, Steven Conway, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 31, 2010
Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infectionYang Zhang, Xiang Li, Heike Grassmé, et al.
Journal of Clinical Microbiology|September 5, 2007
Emergence of an epidemic clone of community-associated methicillin-resistant panton-valentine leucocidin-negative Staphylococcus aureus in cystic fibrosis patient populationsSilvia Campana, Priscilla Cocchi, Gerd Döring, et al.
Journal of Bacteriology|October 18, 2003
Molecular architecture of the regulatory Locus sae of Staphylococcus aureus and its impact on expression of virulence factorsAndrea Steinhuber, Christiane Goerke, Manfred G Bayer, et al.
Pageof 7